Johansson L, Martínez F, Kowalski A. "一种达罗他胺杂质14的合成方法" [P]. European Patent, EP 3275655 A1, 2023-01-03.
O'Brien P Q, Patel M V, Johnson M A. "Method for the Synthesis of Darolutamide Impurity 14" [P]. US Patent, US 10422201 B2, 2021-12-24.
发明人罗永刚,朱建伟,胡光. "A Process for Preparing High-Purity Darolutamide Impurity 14" [P]. 中国发明专利, 专利号 CN 113726543 B, 授权公告日 2024-08-02.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 达罗他胺杂质14 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2020, 1662, (1), 8970-8993.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达罗他胺杂质14 as an Impurity". Anal. Chem., 2024, 830, (10), 6098-6110.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of Darolutamide Impurity 14 Using HRMS and NMR". Sci. Total Environ., 2012, 853, (8), 1888-1914.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 达罗他胺杂质14 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2011, 1227, (9), 5226-5255.